Portland, ME, United States of America

Daniel Wayne Patch

This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Idexx Laboratories, Inc.. Active years: 2020-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Daniel Wayne Patch

Introduction

Daniel Wayne Patch is an accomplished inventor based in Portland, ME (US). He has made significant contributions to the field of immunoassays, holding a total of 2 patents. His work focuses on enhancing the accuracy and reliability of diagnostic tests through innovative methodologies.

Latest Patents

One of his latest patents is titled "Homogenous immunoassay with compensation for background signal." This invention allows for compensation of background signals that are often inherent in samples and reagents. It specifically addresses the detection of symmetrical Dimethyl Arginine (SDMA) in biological samples. The patent also includes the development of reagents and kits for conducting these assays, further advancing the capabilities of diagnostic testing.

Career Highlights

Daniel Wayne Patch is currently employed at IDEXX Laboratories, Inc., a company renowned for its commitment to innovation in veterinary diagnostics and water testing. His role at IDEXX has allowed him to apply his expertise in immunoassays to develop solutions that improve diagnostic accuracy.

Collaborations

Throughout his career, Daniel has collaborated with notable colleagues, including Murthy V S N Yerramilli and Hongzhi Xie. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Daniel Wayne Patch exemplifies the spirit of innovation in the field of immunoassays. His contributions through patents and collaborations continue to impact the diagnostic industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…